Pharmaceutical composition for preventing and treating oophoroma and preparation method thereof

A composition and ovarian cancer technology, applied in the field of pharmaceutical compositions for the prevention and treatment of ovarian cancer, can solve the problems of no unified syndrome differentiation and no in-depth discussion of theoretical research, and achieve remarkable curative effect

Inactive Publication Date: 2015-12-02
JINAN XINGYI MEDICAL TECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there are still many problems in the treatment. For example, the application of traditional Chinese medicine in the prevention and treatment of ovarian cancer does not have a unified syndrome differentiation. Commitment should be devoted to the combination of theoretical research, experimental research and clinical practice of traditional Chinese medicine, so as to fully understand the mechanism and curative effect of traditional Chinese medicine in the prevention and treatment of ovarian cancer, and actively explore effective ways of traditional Chinese medicine to improve clinical efficacy, so that postoperative cooperation with traditional Chinese medicine treatment or The curative effect and 5-year survival rate of traditional Chinese medicine treatment are greatly improved

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing and treating oophoroma and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0038] Embodiment 1: the pharmaceutical composition of preventing and treating ovarian cancer and preparation method thereof

[0039] The composition and parts by weight of the bulk drug of the pharmaceutical composition for preventing and treating ovarian cancer are:

[0040] 55 parts by weight of Artemisia argentina 105 parts by weight of Artemisia arvenii 35 parts by weight of Lapis lazuli 25 parts by weight of the medicine picroside 7 parts by weight of demethyl gentianone 4 parts by weight;

[0041] Preparation:

[0042] (1) According to the ratio of raw materials, take Artemisia arborii and Ayurveda fruit, mix them evenly, first use 60% ethanol as a solvent, and extract at 50°C by warm soaking. The number of extractions is 4 times, and the extraction time is 4 times each time. hour, each solvent dosage is 20 times of the total weight of Artemisia arborii and Ayurveda fruit medicinal materials, filter to obtain dregs A and extract, the extract reclaims ethanol, concentra...

Embodiment 2

[0046] Embodiment 2: the pharmaceutical composition of preventing and treating ovarian cancer and preparation method thereof

[0047] The composition and parts by weight of the bulk drug of the pharmaceutical composition for preventing and treating ovarian cancer are:

[0048] 60 parts by weight of Artemisia arborii 100 parts by weight of Artemisia arborii 40 parts by weight of Lapis lazuli 20 parts by weight of the medicine picroside 8 parts by weight of demethyl gentianone 3 parts by weight;

[0049] Preparation:

[0050] (1) According to the ratio of raw materials, take Artemisia arborii and Ayurveda fruit, mix them evenly, first use 60% ethanol as a solvent, and extract at 50°C by warm soaking. The number of extractions is 4 times, and the extraction time is 4 times each time. hour, each solvent dosage is 20 times of the total weight of Artemisia arborii and Ayurveda fruit medicinal materials, filter to obtain dregs A and extract, the extract reclaims ethanol, concentrate...

Embodiment 3

[0054] Embodiment 3: the pharmaceutical composition of preventing and treating ovarian cancer and preparation method thereof

[0055] The composition and parts by weight of the bulk drug of the pharmaceutical composition for preventing and treating ovarian cancer are:

[0056] 50 parts by weight of Artemisia arborii 110 parts by weight Ayurveda 30 parts by weight lapis lazuli 30 parts by weight as medicine picroside 6 parts by weight demethyl gentianone 5 parts by weight;

[0057] Preparation:

[0058] (1) According to the ratio of raw materials, take Artemisia arborii and Ayurveda fruit, mix them evenly, first use 60% ethanol as a solvent, and extract at 50°C by warm soaking. The number of extractions is 4 times, and the extraction time is 4 times each time. hour, each solvent dosage is 20 times of the total weight of Artemisia arborii and Ayurveda fruit medicinal materials, filter to obtain dregs A and extract, the extract reclaims ethanol, concentrates, and dries to obtain...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for preventing and treating oophoroma. The pharmaceutical composition disclosed by the invention is prepared from lancea tibetica, artemisia adamsii besser, trachyspermum ammi, lasurite, swertiamarin and demethylbellidifolin as raw medicines in proportion. The pharmaceutical composition can be prepared into various dosage forms according to conventional preparation processes and has obvious curative effects on preventing and treating oophoroma.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition for preventing and treating ovarian cancer. Background technique [0002] Ovarian cancer is one of the three common malignant tumors of the female reproductive system, accounting for about 20% of female reproductive tract malignant tumors, and the incidence rate in China ranks third after cervical and body cancers. It lacks early specific symptoms and is highly occult. About two-thirds of them are already in the middle and advanced stages when they are discovered. The 5-year survival rate hovers between 30% and 40%, and the case fatality rate ranks first among gynecological malignancies. At present, comprehensive treatment based on surgery and chemotherapy is usually used clinically, but with the deepening of treatment, the toxic side effects of chemotherapy drugs and the drug resistance of the body have become increasingly promi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/80A61P35/00A61K33/06A61K31/352A61K31/7048
Inventor 张秀华
Owner JINAN XINGYI MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap